3. Duplicative Therapy
Concurrent administration of multiple LMWH products does not provide additional therapeutic benefit and is not recommended. Patient profiles containing concomitant prescriptions for two or more LMWH products will be reviewed.
Official websites use the Texas HHS logo.
The Texas HHS logo means this is an official website of Texas Health and Human Services.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.